| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a76a021ba01e616e30aa9c08b70c1192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55b8e60ca631f6d4606b3509782f8582 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate |
2007-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f6c69b72637f4bef7cf39c820883341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a2b505db1f3c163e7b38c8bd1dae287 |
| publicationDate |
2011-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011162437-A1 |
| titleOfInvention |
Biomarker for Mitochondrial Toxicity Associated with Phospholipidosis |
| abstract |
The present invention relates to a method for determining a risk of a phospholipidotic compound for inducing mitochondrial toxicity which is associated with drug-induced phospholipidosis, comprising a) measuring the level of PAG in a body fluid, b) comparing the level of determined PAG with the level of PAG of a control wherein an increased level of PAG in comparison with that control is indicative that said compound induces mitochondrial toxicity which is associated with drug-induced phospholipidosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018213389-A1 |
| priorityDate |
2006-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |